Big Pharma Lobbyist On White House Deal: "It's Counterproductive To Keep Talking About It"

An $80-billion deal with the drug industry that the White House thought would add momentum to its campaign for national healthcare reform has instead provoked a political tempest, frustrating and bewildering some of the president's most important allies.

As complaints rolled in, the administration offered varying, sometimes contradictory explanations of the deal.

Read more on L.A. Times